U.S. MarketsJune 8 at 08:05 AM

Pfizer (PFE) said it is optimistic lyme disease vaccine will get registration after 70%-plus efficacy data; says it continues to beat the expectations for revenue or EPS in '24, '25, and Q1 '26

News detail

China is becoming a "scientific superpower" and its future competition may be Chinese mega players rather than Eli Lilly (LLY) or AstraZeneca (AZN LN) in five years.

3 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

Geopolitics

Gulf official tells CNN “50:50” chance US and Iran could reach deal by Friday, CNN reports; Iranian delegation does not include IRGC, which would need to sign off on details of provisional agreement

Geopolitics

The draft agreed to by Iranian and Omani negotiators awaits final approval from Iran’s supreme leader, two regional officials told The Associated Press on Wednesday

U.S. Economy